USD 20.54
(19.07%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 10.11 Million USD | -16.9% |
2022 | 12.16 Million USD | 80.47% |
2021 | 6.74 Million USD | 1086.97% |
2020 | 568 Thousand USD | -74.82% |
2019 | 2.25 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2001 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.87 Million USD | -15.89% |
2024 Q2 | 2.49 Million USD | 0.0% |
2023 Q2 | 12.4 Million USD | 313.63% |
2023 Q1 | 3 Million USD | -75.34% |
2023 Q3 | 3 Million USD | -75.82% |
2023 Q4 | 10.11 Million USD | 237.03% |
2023 FY | 10.11 Million USD | -16.9% |
2022 Q1 | 6.27 Million USD | -6.99% |
2022 Q4 | 12.16 Million USD | -1.34% |
2022 Q2 | 13.83 Million USD | 120.54% |
2022 FY | 12.16 Million USD | 80.47% |
2022 Q3 | 12.33 Million USD | -10.83% |
2021 Q1 | 499 Thousand USD | -12.15% |
2021 FY | 6.74 Million USD | 1086.97% |
2021 Q4 | 6.74 Million USD | 13.37% |
2021 Q3 | 5.94 Million USD | 0.81% |
2021 Q2 | 5.89 Million USD | 1082.16% |
2020 Q2 | 2.36 Million USD | 10.27% |
2020 Q3 | 2.23 Million USD | -5.59% |
2020 Q4 | 568 Thousand USD | -74.54% |
2020 FY | 568 Thousand USD | -74.82% |
2020 Q1 | 2.14 Million USD | -5.01% |
2019 Q4 | 2.25 Million USD | -4.65% |
2019 Q2 | 2.38 Million USD | -4.14% |
2019 FY | 2.25 Million USD | 0.0% |
2019 Q1 | 2.48 Million USD | 0.0% |
2019 Q3 | 2.36 Million USD | -0.8% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2001 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 3.07 Million USD | -228.92% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -1267.9% |
Aspira Women's Health Inc. | 1.43 Million USD | -607.063% |
Biodesix, Inc. | 35.22 Million USD | 71.296% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -10137.64% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -804.004% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -804.004% |
Bionano Genomics, Inc. | 7.17 Million USD | -40.92% |
CareDx, Inc | 28.27 Million USD | 64.244% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 14.19 Million USD | 28.786% |
DarioHealth Corp. | 24.59 Million USD | 58.883% |
Exact Sciences Corporation | 2.47 Billion USD | 99.592% |
Guardant Health, Inc. | 1.13 Billion USD | 99.113% |
ICON Public Limited Company | 3.66 Billion USD | 99.724% |
IDEXX Laboratories, Inc. | 622.88 Million USD | 98.377% |
Illumina, Inc. | 1.48 Billion USD | 99.321% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -12332.984% |
iSpecimen Inc. | 29.13 Thousand USD | -34609.921% |
Standard BioTools Inc. | 3.98 Million USD | -153.854% |
MDxHealth SA | 35.56 Million USD | 71.57% |
23andMe Holding Co. | 67.84 Million USD | 85.097% |
Medpace Holdings, Inc. | 142.12 Million USD | 92.886% |
Myriad Genetics, Inc. | 130.9 Million USD | 92.276% |
Mainz Biomed B.V. | 2.19 Million USD | -360.451% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -5164.446% |
NeoGenomics, Inc. | 606.06 Million USD | 98.332% |
Neogen Corporation | 888.39 Million USD | 98.862% |
Inotiv, Inc. | 399.4 Million USD | 97.469% |
Natera, Inc. | 282.94 Million USD | 96.427% |
OPKO Health, Inc. | 222.03 Million USD | 95.446% |
Psychemedics Corporation | 945 Thousand USD | -969.947% |
Prenetics Global Limited | 867.21 Thousand USD | -1065.916% |
Prenetics Global Limited | 867.21 Thousand USD | -1065.916% |
Precipio, Inc. | 106 Thousand USD | -9438.679% |
Personalis, Inc. | 1.23 Million USD | -719.368% |
RadNet, Inc. | 812.06 Million USD | 98.755% |
Sera Prognostics, Inc. | 840 Thousand USD | -1103.69% |
Sotera Health Company | 2.22 Billion USD | 99.545% |
Neuronetics, Inc. | 59.28 Million USD | 82.945% |
Star Equity Holdings, Inc. | 1.14 Million USD | -783.057% |
Star Equity Holdings, Inc. | 1.14 Million USD | -783.057% |
Trinity Biotech plc | 54.65 Million USD | 81.499% |
Twist Bioscience Corporation | 79.17 Million USD | 87.229% |
Exagen Inc. | 19.23 Million USD | 47.423% |